However, a possible contribution of factors such as age and disease do not explain the striking dominance of high-dose regimens in these experiments, thereby suggesting that estrogens in supraphysiological concentrations are likely to have a higher propensity for increasing inflammation, supporting the hypothesis that high-dose estrogens increase damage from cerebral ischemia.